- Report
- March 2024
- 185 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- March 2024
- 185 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- December 2023
- 120 Pages
Global
From €5721EUR$5,950USD£4,908GBP
- Report
- January 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- October 2023
- 140 Pages
Global
From €2403EUR$2,499USD£2,061GBP
- Report
- April 2024
- 180 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 110 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- April 2022
- 264 Pages
Global
From €5769EUR$6,000USD£4,949GBP
- Report
- August 2020
Global
From €4760EUR$4,950USD£4,083GBP
- Report
- October 2023
- 207 Pages
India
From €3798EUR$3,950USD£3,258GBP
- Report
- January 2022
- 116 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- March 2020
- 117 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Book
- August 2022
- 560 Pages
- Book
- August 2023
North America
The Fungal Infection market within the context of Infectious Disease Testing is a rapidly growing sector of the healthcare industry. Fungal infections are caused by a variety of fungi, including yeasts, molds, and other organisms. These infections can range from mild to severe and can be difficult to diagnose and treat. Infectious Disease Testing is used to identify the presence of fungal infections in patients, allowing for more effective treatment. Tests used to diagnose fungal infections include blood tests, skin tests, and imaging tests.
The Fungal Infection market is driven by the increasing prevalence of fungal infections, the development of new diagnostic technologies, and the rising demand for more accurate and timely diagnosis. The market is also driven by the increasing availability of antifungal drugs and the growing awareness of the importance of early diagnosis and treatment.
Some companies in the Fungal Infection market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more